[APLS] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
13-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -7.91%
YoY- -210.83%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 5,650 646 0 0 0 0 0 -
PBT -195,571 -135,700 -69,825 -35,972 -11,573 -7,211 -31,632 35.43%
Tax 2,165 9,483 540 -281 -11,589 -7,234 -442 -
NP -195,571 -135,700 -69,825 -35,972 -11,573 -7,211 -31,189 35.75%
Tax Rate - - - - - - - -
Total Cost 201,221 136,346 69,825 35,972 11,573 7,211 31,189 36.40%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -3,461.43 -21,006.19 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -2.28 -1.79 -1.10 -0.64 -0.30 -0.40 -1.72 4.80%
EPS Diluted -2.28 -1.79 -1.10 -0.64 -0.30 -0.40 -1.72 4.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.